Business Context and Reporting Period
This Form 8-K Current Report is filed by MRI Interventions, Inc. (Note: The request metadata lists "Clearpoint Neuro, Inc.", but the filing text identifies the registrant as MRI Interventions, Inc.) for the event date of May 25, 2017. The report details the entry into a Material Definitive Agreement regarding a private placement financing transaction.
Key Financial Metrics and Transaction Details
- Transaction Type: Private placement of 6,625,000 Units.
- Unit Composition: One share of common stock and one warrant to purchase one share of common stock per unit.
- Purchase Price: $2.00 per unit.
- Gross Proceeds: Approximately $13.25 million.
- Warrant Terms: Exercise price of $2.20 per share; exercisable for five years; includes cashless exercise feature.
- Placement Agents: Joseph Gunnar & Co., LLC (lead) and Brookline Capital Markets (division of CIM Securities, LLC).
- Compensation: Agents to receive cash commissions and Placement Agent Warrants.
Material Changes and Agreements
The primary material change is the execution of a Securities Purchase Agreement and a Registration Rights Agreement. The Company agreed to file a registration statement with the SEC within 30 calendar days of the closing to cover the resale of shares issued to investors and shares underlying the warrants. Failure to file or maintain the effectiveness of this registration statement may result in liquidated damages payable to investors.
Guidance, Outlook, and Risks
- Closing Timeline: The Company anticipates closing the transaction on or before May 26, 2017, subject to customary closing conditions.
- Future Closings: The Company reserves the right to enter into additional securities purchase agreements and hold additional closings for the sale of Units.
- Risks: The filing contains forward-looking statements subject to risks and uncertainties. There is no assurance the transaction will close on the described terms or in a timely manner. Risks include market conditions and the satisfaction of closing conditions.
- Unregistered Sales: Securities are being sold to accredited investors in reliance on exemptions under Section 4(a)(2) of the Securities Act and Rule 506.
Investor Verification Checklist
- Verify the actual closing date and confirmation of the $13.25 million gross proceeds.
- Confirm the filing of the Registration Statement within the required 30-day window to avoid liquidated damages.
- Review the full text of the Securities Purchase Agreement (Exhibit 10.1) and Warrant (Exhibit 4.1) for specific covenants and adjustment mechanisms.
- Monitor for any additional closings or changes to the number of Units sold as permitted by the agreement.
- Check subsequent filings for the effective date of the registration statement covering investor shares.